Saturday, August 2, 2025

Sensex falls over 1 pc; Reliance drags

Date:

Mumbai: Benchmark equity indices declined on Tuesday, a day after recording sharp gains, with the BSE Sensex falling over 1 per cent due to selling in Reliance Industries, ITC and Bajaj Finance.

The 30-share BSE Sensex fell by 801.67 points or 1.11 per cent to settle at 71,139.90. During the day, it plummeted 865.85 points or 1.20 per cent to 71,075.72.

The Nifty declined 215.50 points or 0.99 per cent to 21,522.10.

Among the Sensex firms, Bajaj Finance fell by 5.03 per cent after its December quarter earnings failed to cheer investors.

Titan, UltraTech Cement, Bajaj Finserv, Reliance Industries, ITC and NTPC were among the other major laggards.

Tata Motors, State Bank of India, Hindustan Unilever, Power Grid, Tech Mahindra and Tata Consultancy Services were the gainers.

In Asian markets, Tokyo settled in the positive territory while Seoul, Shanghai and Hong Kong ended lower.

European markets were trading with gains. The US markets ended higher on Monday.

The BSE benchmark jumped 1,240.90 points or 1.76 per cent to settle at 71,941.57 on Monday. The Nifty climbed 385 points or 1.80 per cent to 21,737.60.

Global oil benchmark Brent crude climbed 0.21 per cent to USD 82.57 a barrel.

Foreign Institutional Investors (FIIs) bought equities worth Rs 110.01 crore on Monday, according to exchange data.

PTI

Related articles

Smart Meter Standoff: West Bengal Pauses Amid Bill Backlash, Karnataka Continues Deployment Despite Public Concern

West Bengal Halts Smart Meter Deployment for Residential Users Following Backlash on Excessive Bills June 11, 2025 –Responding to...

Maharashtra’s New Social Media Guidelines for Government Employees | Freedom of Speech or Control? | Digital Discipline or Silent Dictatorship?

The Maharashtra government has ordered employees to follow new social media guidelines that ban employees from criticizing currently,...

The Need for Integrative Thinking in Medicine: A Critical Analysis of COVID-19 Vaccine Rollout in India – Dr. Amitav Banerjee

NIMHANS Bengaluru Research Fuels Urgent Call for Critical Appraisal of India’s COVID-19 Vaccine Rollout Amidst Neurological Concerns As India...

Improving Public Education on Cervical Cancer: Dr. Maya Valecha’s Insights

Concerns Surrounding the Cervical Cancer Vaccine in India An article by Dr. Maya Valecha critiques the Indian government's promotion...